Stockscreener 앱 받기
5.41
20.91%
-1.43
시간 외 거래:
5.77
0.36
+6.65%
전일 마감가:
$6.84
열려 있는:
$6.1
하루 거래량:
52,943
Relative Volume:
0.90
시가총액:
$24.40M
수익:
$86.55M
순이익/손실:
$-56.70M
주가수익비율:
-2.104
EPS:
-2.5713
순현금흐름:
$4.87M
1주 성능:
-18.40%
1개월 성능:
+25.52%
6개월 성능:
-13.04%
1년 성능:
+53.65%
1일 변동 폭
$5.41
$6.395
1주일 범위
$5.41
$7.50
52주 변동 폭
$2.813
$9.458
Harvard Bioscience Inc Stock (HBIO) Company Profile
명칭
Harvard Bioscience Inc
전화
(508) 893-8999
주소
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
5.41 | 30.85M | 86.55M | -56.70M | 4.87M | -2.5713 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 개시 | Northland Capital | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-01-24 | 재확인 | Janney | Buy |
| 2018-01-23 | 재확인 | The Benchmark Company | Buy |
| 2016-11-17 | 개시 | Singular Research | Buy |
| 2015-07-28 | 개시 | The Benchmark Company | Buy |
모두보기
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience Q1 2026 Earnings Call Transcript - MarketBeat
Harvard Bioscience (HBIO) Reports Q1 Earnings and Reaffirms 2026 Revenue Guidance - GuruFocus
Discontinued operations of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
[10-Q] HARVARD BIOSCIENCE INC Quarterly Earnings Report - Stock Titan
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New Product Innovations - GuruFocus
Harvard Bioscience, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
HBIO Forecasts Q2 Margins and Revenue Growth - GuruFocus
Earnings call transcript: Harvard Bioscience Q1 2026 misses EPS forecast, stock drops - Investing.com UK
HBIO Maintains Positive Outlook for FY26 Financial Performance - GuruFocus
HBIO Sees Q1 Revenue at $20.8M, Positive Trends in Product Adoption - GuruFocus
Harvard Bioscience reaffirms 2026 outlook for 2%-4% revenue growth as Project Viking targets $4M annual savings - MSN
Harvard Bioscience Still Sees 2026 Revenue Up 2%-4% >HBIO - Moomoo
Harvard Bioscience Q1 2026 slides: margins rise amid revenue miss By Investing.com - Investing.com Australia
Harvard Bioscience (HBIO) Q1: EPS Not Disclosed, Revenue $20.8M - GuruFocus
Harvard Bioscience Announces Q1 2026 Financial Results: $20.8M Revenue, 59% Gross Margin, Key SEC Filing Details 9 - Minichart
Harvard Bioscience Accelerates Growth with Human-Relevant Translational Tools, Leading Recurring Revenue and Innovation in Preclinical Research (May 2026) 10121415 - Minichart
Harvard Bioscience Still Sees 2026 Adjusted Ebitda Up 6%-10% >HBIO - Moomoo
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat - ChartMill
HARVARD BIOSCIENCE ($HBIO) Releases Q1 2026 Earnings - Quiver Quantitative
Harvard Bioscience Announces First Quarter 2026 Financial Results - The Manila Times
Harvard Bioscience: Q1 Earnings Snapshot - marketscreener.com
Harvard Bioscience (NASDAQ: HBIO) details debt refinancing, FY26 outlook and $7M convertible loan - Stock Titan
Harvard Bioscience (NASDAQ: HBIO) Q1 2026 margin up as loss shrinks - Stock Titan
Harvard Bioscience narrows quarterly loss as margins rise - Stock Titan
Inventory turnover of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
MSN Money - MSN
Harvard Bioscience Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView
Harvard Bioscience to Participate in Upcoming Investor Conferences - 富途牛牛
HBIO News | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
When Should You Buy Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
Earnings Preview: HBIO to Report Financial Results Pre-market on May 12 - Moomoo
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET - marketscreener.com
HBIO Harvard Bioscience Inc. posts 100 percent Q4 2025 EPS miss vs estimates, shares rise 3.72 percent in today's trading.Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Harvard Bioscience (HBIO) Quarterly Preview | Q4 2025: Below ExpectationsOpen Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Harvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN
Will Harvard Bioscience Inc outperform tech stocks2026 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Options Flow: Whats the fair value of Harvard Bioscience Inc stockPortfolio Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn
Profit Recap: What are analysts price targets for Harvard Bioscience IncPrice Action & Low Volatility Stock Suggestions - baoquankhu1.vn
HBIO | Harvard Bioscience Inc Insider Trading - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Intraday SessionCDT Equity (NASDAQ:CDT), Cue Biopharma (NASDA - Benzinga
Published on: 2026-04-06 23:13:26 - baoquankhu1.vn
Harvard Bioscience Inc (HBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):